Novo Holdings A/S’s CARGO Therapeutics CRGX Stock Holding History

Novo Holdings A/S’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,663,724	Closed	-$24M	–	32
2024 Q4	$24M	Buy	1,663,724 +119,724	+8%	+$2.17M	1.45%	19
2024 Q3	$28.5M	Hold	1,544,000	–	–	1.41%	23
2024 Q2	$25.4M	Buy	1,544,000 +294,000	+24%	+$5.59M	1.37%	24
2024 Q1	$27.9M	Hold	1,250,000	–	–	1.92%	19
2023 Q4	$28.9M	Buy	+1,250,000	New	+$21.2M	1.79%	22

Other funds holding CRGX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGV

TRV GP VI Boston, Massachusetts $136M AUM 328.39% 1-Year Est. Return

Novo Holdings A/S's CRGX Position: Q1 2025 in Review

Novo Holdings A/S sold out of CARGO Therapeutics (CRGX) in Q1 2025, closing a stake of 1,663,724 shares — an estimated $24M sold.

Novo Holdings A/S first reported a position in CRGX in Q4 2023 and held it in 5 quarters. The position peaked at $28.9M in Q4 2023. 113 funds tracked by Wall St. Rank hold CRGX as of Q1 2025.

Novo Holdings A/S reported no remaining CARGO Therapeutics position as of Q1 2025 after selling out during the quarter.
Novo Holdings A/S sold 1,663,724 CARGO Therapeutics shares in Q1 2025, an estimated $24M.
Novo Holdings A/S first reported a position in CARGO Therapeutics in Q4 2023 and held it in 5 quarters.
Novo Holdings A/S's CARGO Therapeutics position peaked at $28.9M in Q4 2023.
113 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q1 2025.

Based on Novo Holdings A/S's 13F filing for Q1 2025, filed 15 May 2025.